Mechanistic analysis of a synthetic inhibitor of the Pseudomonas aeruginosa LasI quorum-sensing signal synthase

Abstract

Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen responsible for many human infections. LasI is an acyl-homoserine lactone synthase that produces a quorum-sensing (QS) signal that positively regulates numerous P. aeruginosa virulence determinants. The inhibition of the LasI protein is therefore an attractive drug target. In this study, a novel in silico to in vitro complementation was applied to screen thiazolidinedione-type compounds for their ability to inhibit biofilm formation at concentrations not affecting bacterial growth. The compound (z)-5-octylidenethiazolidine-2, 4-dione (TZD-C8) was a strong inhibitor of biofilm formation and chosen for further study. Structural exploration of in silico docking predicted that the compound had high affinity for the LasI activity pocket. The TZD-C8 compound was also predicted to create hydrogen bonds with residues Arg30 and Ile107. Site-directed mutagenesis (SDM) of these two sites demonstrated that TZD-C8 inhibition was abolished in the lasI double mutant PAO-R30D, I107S. In addition, in vitro swarming motility and quorum sensing signal production were affected by TZD-C 8, confirming this compound alters the cell to cell signalling circuitry. Overall, this novel inhibitor of P. aeruginosa quorum sensing shows great promise and validates our mechanistic approach to discovering inhibitors of LuxI-type acyl-homoserine lactone synthases.

Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

“…A follow-up report detailed the optimization of mBTL for enhanced stability, as the thiolactone ring is susceptible to chemical and enzymatic hydrolysis (110). Other anti-quorum-sensing agents (111)(112)(113)(114) have also been reported to exhibit similar promising in vitro and in vivo results. However, this paradigm was recently challenged (115,116), and several clinical isolates have been reported to be resistant to established anti-quorum-sensing agents (117).…”

Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspired Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents

“…The bacterial biofilm colonies were allowed to grow for 48 h at 30 °C, after which the colony was immersed in 0.4% paraformaldehyde followed by the removal of the colony with double distilled water washes. In order to test the amount of CR that remained on the agar after the removal of the colonies, the agar was dissolved as previously described (135). In brief, the agar underneath the removed colony was cut out, and incubated at 55 °C for 10 min with 1 ml of binding buffer solution (hylabs, Rehovot, Israel).…”

Scaffold of Selenium Nanovectors and Honey Phytochemicals for Inhibition of Pseudomonas aeruginosa Quorum Sensing and Biofilm Formation

“…Emergence of multi-drug resistant bacteria has driven studies for disabling virulence preferentially through quorum sensing (QS) inhibition tactics instead of bactericidal and bacteriostatic strategies (Singh et al, 2009a; Defoirdt et al, 2013; Kim et al, 2015; Lidor et al, 2015; Srivastava et al, 2015; Wang et al, 2015; Yang et al, 2015). P. aeruginosa , a Gram-negative bacterium causes cystic fibrosis in immunocompromised patients, burn units of hospitals, and in implanted medical devices including intubation tubes and stents (Singh et al, 2012; Singh B. R. et al, 2015; Kalferstova et al, 2016).…”